Squarepoint Ops LLC Galmed Pharmaceuticals Ltd. Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.75 - $3.03 $44,457 - $76,974	-25,404 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.41 - $3.33 $17,424 - $24,075	-7,230 Reduced 22.15%	25,404 $71,000
Q2 2021 Aug 16, 2021	SELL	$2.24 - $3.9 $49,840 - $86,775	-22,250 Reduced 40.54%	32,634 $99,000
Q1 2021 May 17, 2021	BUY	$3.19 - $5.4 $108,058 - $182,919	33,874 Added 161.23%	54,884 $188,000
Q4 2020 Feb 16, 2021	SELL	$3.06 - $4.17 $9,222 - $12,568	-3,014 Reduced 12.55%	21,010 $65,000
Q3 2020 Nov 16, 2020	BUY	$3.46 - $5.69 $83,123 - $136,696	24,024 New	24,024 $85,000
Q2 2020 Aug 14, 2020	SELL	$3.22 - $6.08 $110,607 - $208,848	-34,350 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.3 - $6.84 $79,909 - $165,630	24,215 Added 238.92%	34,350 $119,000
Q4 2019 Feb 14, 2020	BUY	$3.61 - $6.75 $36,587 - $68,411	10,135 New	10,135 $59,000
Q1 2019 May 15, 2019	SELL	$7.27 - $9.07 $117,047 - $146,027	-16,100 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$6.59 - $14.47 $102,988 - $226,137	-15,628 Reduced 49.26%	16,100 $110,000
Q3 2018 Nov 14, 2018	BUY	$10.55 - $15.28 $334,730 - $484,803	31,728 New	31,728 $431,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $68.7M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.